Vitamin B12 markets in the United States slipped modestly late February after range-bound activity, amid cautious imports and steady distributor inventories that kept supply balanced. Early and mid-month trading featured routine replenishment and steady offshore production that supported discipline, while late-month sentiment softened as buyers retrenched from incremental coverage. The February narrative centred on steady underlying demand from nutraceutical and fortified-food formulators, offset by conservative purchasing from traders and importers, resulting in limited spot activity within a narrow band. Demand dynamics for CFR Los Angeles were a key driver of the month's level, with a monthly assessment showing a modest uptick from the prior reference, even as weekly readings fluctuated. Industry data indicated a cautious but resilient market, with supply cycles remaining regular and no major disruptions reported. Looking forward, upside and downside risks depend on importer coverage, distributor inventory behaviour, and offshore shipment schedules. A bullish bias persists on a moving average, with direction tied to buyer risk appetite.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
